Literature DB >> 5339044

Methodology of multiclinic therapeutic trials in hypertension.

E D Freis.   

Abstract

Entities:  

Mesh：

Year:  1967        PMID： 5339044      PMCID： PMC1923118     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  THE EVALUATION OF ANTIHYPERTENSIVE THERAPY COOPERATIVE CLINICAL TRIAL METHOD. I. DOUBLE-BLIND CONTROL COMPARISON OF CHLOROTHIAZIDE, RAUWOLFIA SERPENTINA, AND HYDRALAZINE.

Authors:  W M SMITH; A N DAMATO; N J GALLUZZI; C F GARFIELD; E G HANOWELL; W H STIMSON; R H THURM; J J WALSH; L BROMER
Journal:  Ann Intern Med       Date:  1964-11       Impact factor: 25.391

2.  Riboflavin marker in drug products.

Authors:  J V SWINTOSKY
Journal:  J Pharm Sci       Date:  1962-10       Impact factor: 3.534

3.  A DOUBLE blind control study of antihypertensive agents. I. Comparative effectiveness of reserpine, reserpine and hydralazine, and three ganglionic blocking agents, chlorisondamine, mecamyamine, and pentolinium tartrate.

Authors: 
Journal:  Arch Intern Med       Date:  1960-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.